From the General Management of Technology in Health Services - GGTES/Brazilian Health Regulatory Agency (ANVISA), Brasilia, Brazil.
J Patient Saf. 2020 Dec;16(4):e260-e266. doi: 10.1097/PTS.0000000000000671.
This article aims to identify and analyze the legal and regulatory frameworks with an interface with patient safety, considering the historical path of the patient safety policy in Brazil.
This is a historical review based on the relevant literature to the topic such as papers, legislation, and official documents with an interface with public health policies from 1988 to 2019. We also performed a documentary search to include data from the Brazilian Health Regulatory Agency (ANVISA) such as normative and nonnormative regulatory instruments. After organizing the data, the process of content analysis was performed.
We debated initially the historical aspects of sanitary surveillance of health services in addition to main actions taken by the Brazilian Health Regulatory System, which includes sanitary regulation and patient safety challenges. We identified a diversity of regulations published by ANVISA in the past decade related to patient safety, in addiction to sanitary actions. These initiatives culminated in the establishment of the National Patient Safety Program in 2013, followed by other health improvements, such as surveillance, incidents monitoring, and safe practices self-assessment.
The regulation and sanitary actions directed to patient safety in Brazil have increased after the creation of ANVISA. In the face of this activities, the social role played by the Brazilian Health Regulatory System toward the advancement in the field of risk minimization in health services can be highlighted as a protagonist in the process of promoting patient safety.
本文旨在识别和分析与患者安全相关的法律和监管框架,考虑到巴西患者安全政策的历史发展路径。
这是一项基于相关文献的历史回顾,包括与 1988 年至 2019 年期间公共卫生政策相关的论文、立法和官方文件等主题的文献。我们还进行了文献检索,以纳入巴西卫生监管机构(ANVISA)的数据,如规范和非规范监管文书。在整理数据后,我们进行了内容分析。
我们首先讨论了卫生服务卫生监督的历史方面,以及巴西卫生监管系统采取的主要行动,其中包括卫生监管和患者安全挑战。我们发现,ANVISA 在过去十年中发布了许多与患者安全相关的法规,除此之外还有卫生行动。这些举措最终促成了 2013 年国家患者安全计划的建立,随后还采取了其他改善措施,如监督、事件监测和安全实践自我评估。
在 ANVISA 成立后,巴西针对患者安全的监管和卫生行动有所增加。面对这些活动,巴西卫生监管系统在减少卫生服务风险领域的发展中所扮演的社会角色,可以被视为促进患者安全的主角。